Viewing Study NCT06259669

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 10:55 PM

Ignite Modification Date: 2026-02-21 @ 9:24 PM

Study NCT ID: NCT06259669

Status: RECRUITING

Last Update Posted: 2025-12-11

First Post: 2024-02-06

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population

Sponsor: Incyte Corporation

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module